The import of tetracyclines to France shows a consistent declining trend from 459.7 thousand kilograms in 2024 to 406.37 thousand kilograms in 2028. This indicates a negative growth rate each year, with percentage declines of about 3% annually. The compound annual growth rate (CAGR) suggests an average yearly decrease of 3% over this five-year period.
Future trends to watch for include potential changes in domestic production capacity, alterations in pharmaceutical regulations on antibiotics, and global supply chain disruptions. These factors could impact the import volume and should be closely monitored for their effects on supply and demand dynamics in the French market.
